Roche says it is working to enhance lab testing capacity for mpox worldwide

Roche (ROG.S) is actively working to enhance laboratory testing capacity for mpox worldwide, the Swiss pharmaceutical company said on Tuesday.
The World Health Organization last week declared mpox a global public health emergency for the second time in two years as a new variant of the disease, known as clade 1b, spread rapidly in Africa.